Healthcare of Ontario Pension Plan Trust Fund decreased its holdings in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 86.3% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 44,400 shares of the health services provider's stock after selling 278,900 shares during the period. Healthcare of Ontario Pension Plan Trust Fund owned approximately 0.07% of Maximus worth $4,136,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds have also recently added to or reduced their stakes in MMS. V Square Quantitative Management LLC bought a new stake in Maximus in the third quarter worth approximately $25,000. GAMMA Investing LLC lifted its holdings in Maximus by 224.5% in the 2nd quarter. GAMMA Investing LLC now owns 344 shares of the health services provider's stock worth $29,000 after purchasing an additional 238 shares during the last quarter. Blue Trust Inc. boosted its position in Maximus by 201.5% during the second quarter. Blue Trust Inc. now owns 392 shares of the health services provider's stock worth $33,000 after purchasing an additional 262 shares during the period. Archer Investment Corp raised its position in shares of Maximus by 8,788.9% in the second quarter. Archer Investment Corp now owns 800 shares of the health services provider's stock valued at $69,000 after purchasing an additional 791 shares during the period. Finally, Ariadne Wealth Management LP acquired a new stake in shares of Maximus in the second quarter worth $90,000. Institutional investors and hedge funds own 97.21% of the company's stock.
Analyst Ratings Changes
Separately, StockNews.com downgraded shares of Maximus from a "buy" rating to a "hold" rating in a report on Thursday.
Get Our Latest Stock Report on Maximus
Maximus Trading Up 2.8 %
NYSE MMS traded up $2.00 during trading on Friday, reaching $74.50. 707,094 shares of the stock traded hands, compared to its average volume of 1,061,140. The stock's 50-day moving average price is $86.50 and its 200 day moving average price is $87.58. The company has a quick ratio of 1.49, a current ratio of 1.49 and a debt-to-equity ratio of 0.59. The firm has a market cap of $4.49 billion, a price-to-earnings ratio of 14.90 and a beta of 0.77. Maximus, Inc. has a fifty-two week low of $71.75 and a fifty-two week high of $93.97.
Maximus Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Saturday, November 30th. Stockholders of record on Friday, November 15th were issued a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.61%. The ex-dividend date was Friday, November 15th. Maximus's payout ratio is 24.00%.
Insider Buying and Selling
In related news, insider Michelle F. Link sold 1,363 shares of the stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $92.56, for a total transaction of $126,159.28. Following the sale, the insider now owns 6,567 shares of the company's stock, valued at $607,841.52. This represents a 17.19 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 1.40% of the stock is currently owned by corporate insiders.
Maximus Profile
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
See Also
Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.